+6.25%
Today
Loading 1D prices…
Company profile
Replimune Group Inc. Common Stock is classified in Biotechnology: Biological Products (No Diagnostic Substances) within the Health Care sector.
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
WOBURN, MA, United States
Fiscal year end
0331
CIK
1737953
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| AMGNAmgen Inc. Common Stock | $207.9B | $36.8B | +20.98% | $14.23 | -1.63% | Hold |
| GILDGilead Sciences Inc. Common Stock | $161.7B | $29.4B | +28.90% | $6.78 | +0.74% | Buy |
| ARGXargenx SE American Depositary Shares | $55.0B | $4.2B | +31.11% | $19.57 | -2.72% | Buy |
| RVMDRevolution Medicines Inc. Common Stock | $38.8B | $0.0 | — | $-5.95 | -2.78% | Buy |
| BIIBBiogen Inc. Common Stock | — | $9.9B | +13.07% | $8.79 | -0.57% | Buy |
